The effectiveness of three repurposed drugs in preventing serious SARS-CoV-2 infection in non-hospitalized adults
![](./upload/news/image_1661169180_86127984.jpg)
Researchers conducted a phase III clinical trial to test the effectiveness of three repurposed drugs - metformin, ivermectin, and fluvoxamine, in preventing progression to severe COVID-19.